Modification of C-seco taxoids through ring tethering and substituent replacement leading to effective agents against tumor drug resistance mediated by βIII-Tubulin and P-glycoprotein (P-gp) overexpressions

European Journal of Medicinal Chemistry
2017.0

Abstract

In our efforts to improve the efficacy of taxane-based microtubule (MT) stabilizing agents against tumor drug resistance mediated by multiple mechanisms, two clinically relevant factors were focused: i.e., P-glycoprotein and βIII-tubulin overexpression. Based on the structure of C-seco taxoid 1 m (IDN5390) which was believed to more selectively interact with βIII-tubulin than paclitaxel, we prepared a series of C-seco taxoids bearing various 7,9-O-linkages and/or different substituents at C2 and C3' positions. Some of them exhibited much more potent binding affinity to MTs and cytotoxicity than their C-seco parent compounds in drug resistant cells with both mechanisms. SAR analysis indicated that C2 modifications significantly enhanced MT binding but brought ambiguous influence to cytotoxicity whereas 7,9-linkage and C3' modifications enhance cytotoxicity more efficiently than improve MT binding. These observations illustrate a better translation of molecular binding effect to cellular activity by C ring closure and C3' modification than C2 modification in C-seco taxoids.

Knowledge Graph

Similar Paper

Modification of C-seco taxoids through ring tethering and substituent replacement leading to effective agents against tumor drug resistance mediated by βIII-Tubulin and P-glycoprotein (P-gp) overexpressions
European Journal of Medicinal Chemistry 2017.0
Novel C-seco-taxoids possessing high potency against paclitaxel-resistant cancer cell lines overexpressing class III β-tubulin
Bioorganic & Medicinal Chemistry Letters 2009.0
Effects of C7 substitutions in a high affinity microtubule-binding taxane on antitumor activity and drug transport
Bioorganic & Medicinal Chemistry Letters 2011.0
Syntheses and Structure−Activity Relationships of the Second-Generation Antitumor Taxoids:  Exceptional Activity against Drug-Resistant Cancer Cells
Journal of Medicinal Chemistry 1996.0
Syntheses and Structure−Activity Relationships of Taxoids Derived from 14β-Hydroxy-10-deacetylbaccatin III
Journal of Medicinal Chemistry 1997.0
Taxanes with high potency inducing tubulin assembly overcome tumoural cell resistances
Bioorganic & Medicinal Chemistry 2014.0
Structure−Activity Relationships of Ring C-Secotaxoids. 1. Acylative Modifications
Journal of Natural Products 2004.0
Design, Synthesis, and Biological Evaluation of New-Generation Taxoids
Journal of Medicinal Chemistry 2008.0
Synthesis of C2−C3‘N-Linked Macrocyclic Taxoids. Novel Docetaxel Analogues with High Tubulin Activity
Journal of Medicinal Chemistry 2004.0
Quest for Efficacious Next-Generation Taxoid Anticancer Agents and Their Tumor-Targeted Delivery
Journal of Natural Products 2018.0